Amanote Research

Amanote Research

    RegisterSign In

TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?

doi 10.20944/preprints201809.0040.v1
Full Text
Open PDF
Abstract

Available in full text

Date

September 3, 2018

Authors
Kouassi T. KouassiPalanikumar GunasekarDevendra K. AgrawalGopal Jadhav
Publisher

MDPI AG


Related search

TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma

Haematologica
Hematology
2020English

Is Pseudoexfoliation Syndrome a Risk Factor for Cardiovascular Diseases?

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2012English

Endoplasmic Reticulum Stress: A Novel Mechanism and Therapeutic Target for Cardiovascular Diseases

Acta Pharmacologica Sinica
MedicinePharmacology
2016English

NO Is Pivotal in Motor Pathologies, but Is It Harmful or Protective?

2011English

Is TRPV1 a Useful Target in Respiratory Diseases?

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2008English

The Role of Gene TREM-1 at Children Who Have Operation Congenital Heart Diseases

Translational Medicine
2019English

Pivotal Studies of Orphan Drugs Approved for Neurological Diseases

Annals of Neurology
Neurology
2009English

Ghrelin as a Treatment for Cardiovascular Diseases

Hypertension
Internal Medicine
2014English

The Thymus Is a Common Target Organ in Infectious Diseases

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy